MSM. V. Starzhetskaya

M. V. Starzhetskaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


M. V. Starzhetskaya has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The opportunities of the systemic immune-inflammation index usage for a pubertal age children lymphadenopathies complex differential diagnostics

    by D. A. Dzhavadov, E. M. Frantsiyants, V. A. Bandovkina, Yu. Yu. Kozel, V. A. Kovalenko, E. E. Pak, M. V. Starzhetskaya, V. V. Dmitrieva, S. N. Dimitriadi, Ю. Ю. Козель

    Background. Lymphadenopathy in pubertal children is a common pathological condition due to both specific and non-specific reasons. Differential diagnosis of lymphadenopathies is essential for the detection of malignant diseases such as lymphomas.Aim. To evaluate the possibility of using the systemic immune-inflammation index (SII) as an auxiliary method for the differential diagnosis of lymphadenopathies in pubertal children.Materials and methods. The study included 160 pubertal children (11–17 years old), divided into 3 groups: group 1 (n = 40) – children of both sexes (22 (55 %) boys and 18 (45 %) girls) with Hodgkin lymphoma; group 2 (n = 40) – children in equal sex ratio with acute infectious mononucleosis; group 3 (n = 40) – children (n = 40) in equal sex ratio with reactive lymphadenitis. Before treatment indicators of general blood test were determined, followed by calculation of the SII. As the norm, average values of parameters obtained from the results of general blood test of conditionally healthy pubertal children (n = 40) in equal sex ratio were used. Statistical processing of the results was performed using Statistica 10.Results. Average leukocyte counts in pubertal children with acute infectious mononucleosis were higher than normal: 2-fold higher in boys and 2.3-fold higher in girls, due to 3–3.6-fold increase in lymphocytes counts. However, there was about 1.5-fold decrease in the average platelet count in comparison with the norm. In pubertal children with Hodgkin lymphoma, the average values of the leukocytes count were 1.5 times higher in boys, and 1.7 times higher in girls compared to the norm, due to 2.1–2.4-fold increase in neutrophil count, at the same time there was about 1.4-fold increase in platelet count. In pubertal children with acute infectious mononucleosis SII values were 4.5 times lower than normal in boys and 4 times lower in girls. In pubertal children with Hodgkin lymphoma SII values exceeded the norm in boys – 6.7 times, and in girls – 6.5 times.Conclusion. Calculation of the SII based on the results of general blood test can be used as an auxiliary, convenient and easily accessible method which allows identifying patients with lymphadenopathy of unknown origin who need in additional diagnostic methods.


  • ASSESSMENT OF THE EXPRESSION OF MMР-2, MMР-9 AND FIBRONECTIN MARKERS AS PROGRESSION PREDICTORS IN THE PRIMARY TUMOR TISSUE OF LOCALIZED AND GENERALIZED FORMS OF EWING’S SARCOMA IN CHILDREN AND ADOLESCENTS

    by Yu.Yu. Kozel, D.Yu. Yurchenko, E.P. Ulyanova, A.B. Sagakyants, G.A. Mkrtchyan, E.E. Pak, V.V. Dmitrieva, M.V. Starzhetskaya, O.V. Kozyuk, A.I. Bespalova, et al.

    Despite processes of epithelial-mesenchymal transition (EMT) that underlie the development of malignant tumors are described widely, the mesenchymal-epithelial transition (MET), which in its turn promotes the metastasis of various tumors, including Ewing's sarcoma (ES), had been studied very little as yet. Within the framework of pediatric oncopathology, ES is one of the most aggressive and metastatic tumors of bones and soft tissues. The purpose of this research was to analyze the features of the expression of markers of the metastatic phenotype of tumor cells MMP2, MMP9 and FN1 in the tissue of the primary tumor in children and adolescents with various forms of ES prevalence. Materials and methods used: 67 patients with localized (n=26) and generalized (n=41) forms of ES aged 0 to 18 y/o, who have been treated at the Pediatric Oncology Department of the National Medical Research Center for Oncology of the Ministry of Healthcare of Russia (Rostov-on-Don, Russia) in Jan. 2009-Dec. 2019. MMP2, MMP9 and FN1 markers were studied by immunohistochemical method in the primary tumor tissue obtained at the stage of process verification and radical surgical treatment after multi-course polychemotherapy (PCT). Results: MMP2 expression in groups with localized and generalized ES before treatment was 4 (p=0.018) and 4.4 (p=0.001) times higher compared to those after treatment. MMP9 expression in the group with generalized ES before treatment prevailed 1.5 times (p=0.020) in comparison with the group after treatment. The median FN1 expression, on the contrary, was 1.2 times lower in the group with generalized ES before treatment than after (p=0.799). Conclusions: determining the expression level of the MMP2 marker in the primary tumor of ES patients can be used to predict the course of the disease and to evaluate the effect of treatment. Whilst markers MMP9 and FN1 require further expanded research.

  • ASSESSMENT OF THE EXPRESSION OF MMР-2, MMР-9 AND FIBRONECTIN MARKERS AS PROGRESSION PREDICTORS IN THE PRIMARY TUMOR TISSUE OF LOCALIZED AND GENERALIZED FORMS OF EWING’S SARCOMA IN CHILDREN AND ADOLESCENTS

    by Yu.Yu. Kozel, D.Yu. Yurchenko, E.P. Ulyanova, A.B. Sagakyants, G.A. Mkrtchyan, E.E. Pak, V.V. Dmitrieva, M.V. Starzhetskaya, O.V. Kozyuk, A.I. Bespalova, et al.

    Despite processes of epithelial-mesenchymal transition (EMT) that underlie the development of malignant tumors are described widely, the mesenchymal-epithelial transition (MET), which in its turn promotes the metastasis of various tumors, including Ewing's sarcoma (ES), had been studied very little as yet. Within the framework of pediatric oncopathology, ES is one of the most aggressive and metastatic tumors of bones and soft tissues. The purpose of this research was to analyze the features of the expression of markers of the metastatic phenotype of tumor cells MMP2, MMP9 and FN1 in the tissue of the primary tumor in children and adolescents with various forms of ES prevalence. Materials and methods used: 67 patients with localized (n=26) and generalized (n=41) forms of ES aged 0 to 18 y/o, who have been treated at the Pediatric Oncology Department of the National Medical Research Center for Oncology of the Ministry of Healthcare of Russia (Rostov-on-Don, Russia) in Jan. 2009-Dec. 2019. MMP2, MMP9 and FN1 markers were studied by immunohistochemical method in the primary tumor tissue obtained at the stage of process verification and radical surgical treatment after multi-course polychemotherapy (PCT). Results: MMP2 expression in groups with localized and generalized ES before treatment was 4 (p=0.018) and 4.4 (p=0.001) times higher compared to those after treatment. MMP9 expression in the group with generalized ES before treatment prevailed 1.5 times (p=0.020) in comparison with the group after treatment. The median FN1 expression, on the contrary, was 1.2 times lower in the group with generalized ES before treatment than after (p=0.799). Conclusions: determining the expression level of the MMP2 marker in the primary tumor of ES patients can be used to predict the course of the disease and to evaluate the effect of treatment. Whilst markers MMP9 and FN1 require further expanded research.

  • Open Access

    The experience of managing children and adolescents with Ewing’s sarcoma in the Pediatric Oncology Department of the Federal State Budgetary Institution “National Medical Research Center of Oncology”, Ministry of Health of Russia

    by D. Yu. Yurchenko, S. A. Kuznetsov, Yu. Yu. Kozel, E. M. Frantsiyants, G. A. Mkrtchyan, E. Ye. Pak, M. V. Starzhetskaya, A. I. Bespalova, O. P. Popovyan, O. V. Kozuk, et al.

    Relevance. One of the leading positions among malignant tumors of the musculoskeletal system in children and adolescents has recently begun to be occupied by Ewing’s sarcoma (ES). The prognosis of patients suffering from this onconosology remains extremely unfavorable even in the absence of distant metastases and timely initiation of antitumor treatment. The authors present 10 years of experience in the management of pediatric and adolescent patients with ES in the pediatric oncology department of the National Medical Research Center of Oncology, Ministry of Health of Russia.Materials and methods. The study included pediatric and adolescent patients diagnosed with ES of I—IV stages of various localizations, who were treated in the Pediatric Oncology Department of the National Medical Research Center of Oncology, Ministry of Health of Russia in the period from 2009 to 2019. We analyzed 2- and 5-year overall (OS) and event-free (EFS) survival in patients who received combined and complex antitumor treatment for various forms of tumor dissemination according to the EURO-EWING 2008protocol, which included neo-and adjuvant polychemotherapy, including high-dose, radical surgical treatment, and also radiation therapy.Results. The median 5-year OS and EFS in the general group of the studied formulations was 60 and 17 months, respectively. The indicators of 2- and 5-year OS and EFS in patients of the general group were 80.6 % and 56.7 %, 38.6 % and 10.6 %, respectively. The volume of the performed antitumor treatment, as well as the form of the advanced tumor process, did not have a significant effect on OS and EFS indicators (p > 0.05). At the same time, the chances of developing ES in boys were statistically significantly higher by 2.2 times in comparison with girls (95 % confidence interval 1.1—4.3).Conclusion. The obtained OS and EFS indices indicate unsatisfactory results of anticancer therapy and extremely high aggressiveness of the biological behavior of the tumor, regardless of the form of spread of the tumor process.

  • Open Access

    ZEB1 as an additional predictor of tumor progression in Ewingʼs sarcoma. Results of a morphological study on a population of children and adolescents

    by O. I. Kit, D. Yu. Yurchenko, E. P. Ulyanova, D. V. Burtsev, S. A. Kuznetsov, A. B. Sagakyants, E. M. Frantsiyants, G. A. Mkrtchyan, E. Ye. Pak, M. V. Starzhetskaya, et al.

    Relevance. Ewingʼs sarcoma (ES) is a classic representative of the extensive family of ES tumors, which occupies one of the leading positions among the malignant pathology of the musculoskeletal system in children and adolescents. This group is characterized by an extremely large variety of morphological, immunohistochemical, and molecular genetic characters among its representatives. The absence of specific pathognomonic markers for ES, as well as the presence of wide variability of clinical manifestations complicates the differential diagnosis. Materials and methods. The study included patients of childhood and adolescence with a localized and generalized form of ES/PNEТ of various localizations undergoing treatment in the conditions of the Department of Pediatric Oncology of the Federal State Budgetary Research Center for Oncology from 2009 to 2019. As the material, the tissue of the primary tumor of ES/PNEТ from paraffin blocks was used, obtained from 67 patients during the primary biopsy, as well as after the surgical stage as part of a combined or complex treatment. The expression of ZEB1 was determined immunohistochemically.Results. The highest average level of expression of ZEB1 protein was observed in group 4 with a generalized form of ES (surgical material) and amounted to 60.8 ± 2.2 %, the minimum level was detected in group 2 with a localized form of ES (surgical material) and amounted to 29.2 ± 3.0 %. Between groups 2 (localized form) and 4 (generalized form) statistically significant differences were noted (p = 0.026).Conclusion. As a result of an immunohistochemical study, the ZEB1 protein showed its prognostic significance when comparing groups with a localized and generalized form of ES (p = 0.026). The predominance of the expression level of ZEB1 protein in the group with the generalized form statistically significantly increased the chances of metastasis by 3.6 times (95 % CI 1.13-11.8).